<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Referred-in-Senate" bill-type="olc" dms-id="H4F5E800214864DBAA6A76BC951EBB9F1" public-private="public" stage-count="1">
	<form>
		<distribution-code display="yes">IIB</distribution-code>
		<congress display="yes">111th CONGRESS</congress>
		<session display="yes">2d Session</session>
		<legis-num>H. R. 1362</legis-num>
		<current-chamber display="yes">IN THE SENATE OF THE UNITED
		  STATES</current-chamber>
		<action>
			<action-date date="20100929">September 29, 2010</action-date>
			<action-desc>Received; read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name></action-desc>
		</action>
		<legis-type>AN ACT</legis-type>
		<official-title display="yes">To amend the Public Health Service Act to
		  provide for the establishment of permanent national surveillance systems for
		  multiple sclerosis, Parkinson’s disease, and other neurological diseases and
		  disorders.</official-title>
	</form>
	<legis-body display-enacting-clause="yes-display-enacting-clause" id="HE768C4CC7A58410B9CEE016C3AF5F93F" style="OLC">
		<section id="H8A4C60E2B77E4C5A9D07AD0B2FB4AA0E" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>National Neurological Diseases
			 Surveillance System Act of 2010</short-title></quote>.</text>
		</section><section id="H642101B45984491B8E72C71FCF38D167"><enum>2.</enum><header>National
			 neurological diseases surveillance system</header><text display-inline="no-display-inline">Part P of title III of the Public Health
			 Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280g">42
			 U.S.C. 280g et seq.</external-xref>) is amended by adding at the end the
			 following:</text>
			<quoted-block display-inline="no-display-inline" id="H26BF1B14178C431F963FC9393715E06F" style="OLC">
				<section id="HFEF863B4902E429F9D605443ED1A6202"><enum>399V–5</enum><header>Surveillance
				of neurological diseases</header>
					<subsection commented="no" id="H7DAF25DA5BC94873BF2AD04A80D6C84C"><enum>(a)</enum><header>In
				general</header><text>The Secretary, acting through the Director of the Centers
				for Disease Control and Prevention, shall—</text>
						<paragraph commented="no" id="H0A44294D538A4A2984075E0393D9A3F5"><enum>(1)</enum><text>enhance and expand
				infrastructure and activities to track the epidemiology of neurological
				diseases, including multiple sclerosis and Parkinson’s disease; and</text>
						</paragraph><paragraph commented="no" id="H1965528F63364CD7A58C28141A3642AE"><enum>(2)</enum><text>incorporate
				information obtained through such activities into a statistically-sound,
				scientifically-credible, integrated surveillance system, to be known as the
				National Neurological Diseases Surveillance System.</text>
						</paragraph></subsection><subsection commented="no" id="H04D4F8B4F249476E9B4D349F2F105EDF"><enum>(b)</enum><header>Research</header><text>The
				Secretary shall ensure that the National Neurological Diseases Surveillance
				System is designed in a manner that facilitates further research on
				neurological diseases.</text>
					</subsection><subsection id="H833B2939B1D347A2B85EA0500BDE8530"><enum>(c)</enum><header>Content</header><text>In
				carrying out subsection (a), the Secretary—</text>
						<paragraph id="H92BB2B340571429197D00C366AD87829"><enum>(1)</enum><text>shall provide for
				the collection and storage of information on the incidence and prevalence of
				neurological diseases in the United States;</text>
						</paragraph><paragraph commented="no" id="HDAA55B8C901343178883A6CBBC3989D9"><enum>(2)</enum><text>to the extent
				practicable, shall provide for the collection and storage of other available
				information on neurological diseases, such as information concerning—</text>
							<subparagraph commented="no" id="H4D38B447F7824D9CBF9B623E0A3D271C"><enum>(A)</enum><text>demographics and
				other information associated or possibly associated with neurological diseases,
				such as age, race, ethnicity, sex, geographic location, and family
				history;</text>
							</subparagraph><subparagraph commented="no" id="H4417EA09D1FD4796B83F1F1FF40F040F"><enum>(B)</enum><text>risk factors
				associated or possibly associated with neurological diseases, including genetic
				and environmental risk factors; and</text>
							</subparagraph><subparagraph commented="no" id="HC77BCC2EC168425ABBA619C18B234DD6"><enum>(C)</enum><text>diagnosis and
				progression markers;</text>
							</subparagraph></paragraph><paragraph id="HF2F6D4EE67DD438BB42BF5509F308B25"><enum>(3)</enum><text display-inline="yes-display-inline">may provide for the collection and storage
				of information relevant to analysis on neurological diseases, such as
				information concerning—</text>
							<subparagraph id="HC99DEF8B2BBA49FEB613CF7C94192707"><enum>(A)</enum><text>the epidemiology
				of the diseases;</text>
							</subparagraph><subparagraph id="H3AD58F9C1B6647E99021108A5F70A906"><enum>(B)</enum><text>the natural
				history of the diseases;</text>
							</subparagraph><subparagraph id="HDBA53AFB995843108DF8FB26B872A489"><enum>(C)</enum><text>the prevention of
				the diseases;</text>
							</subparagraph><subparagraph id="H78C2AC2F0BCA4C50B33E395B313BAFF6"><enum>(D)</enum><text>the detection,
				management, and treatment approaches for the diseases; and</text>
							</subparagraph><subparagraph id="H9CF9A0533F8742539968CCF7A5E35D00"><enum>(E)</enum><text>the development of
				outcomes measures; and</text>
							</subparagraph></paragraph><paragraph id="HB5EF476424494EA0A51B46A43740CB0A"><enum>(4)</enum><text>may address issues
				identified during the consultation process under subsection (d).</text>
						</paragraph></subsection><subsection id="H2E3F5198814D4A80A9D23E39FDE4E6AF"><enum>(d)</enum><header>Consultation</header><text>In
				carrying out this section, the Secretary shall consult with individuals with
				appropriate expertise, including—</text>
						<paragraph id="HA60F163E346C4F8F8BD849CC0283A89D"><enum>(1)</enum><text>epidemiologists
				with experience in disease surveillance or registries;</text>
						</paragraph><paragraph id="HCCC5C09896DB4430878CFC4CC5A702C5"><enum>(2)</enum><text>representatives of
				national voluntary health associations that—</text>
							<subparagraph id="HD09A9E39914441A69763BDE8CAEB0A6A"><enum>(A)</enum><text>focus on
				neurological diseases, including multiple sclerosis and Parkinson’s disease;
				and</text>
							</subparagraph><subparagraph id="H74A743B9143E48E385FEBF744EFEE790"><enum>(B)</enum><text>have demonstrated
				experience in research, care, or patient services;</text>
							</subparagraph></paragraph><paragraph id="HF64EAB732714468DB3B25BC02DAA94D7"><enum>(3)</enum><text>health information
				technology experts or other information management specialists;</text>
						</paragraph><paragraph id="H2EF74C7DC19C4A3AB369B2E58420E65E"><enum>(4)</enum><text>clinicians with
				expertise in neurological diseases; and</text>
						</paragraph><paragraph id="H9D4F2FB5A96B435CB799DBFC8723B5D3"><enum>(5)</enum><text>research
				scientists with experience conducting translational research or utilizing
				surveillance systems for scientific research purposes.</text>
						</paragraph></subsection><subsection id="HB52905B553654E02A496F83C463D9F3D"><enum>(e)</enum><header>Grants</header><text>The
				Secretary may award grants to, or enter into contracts or cooperative
				agreements with, public or private nonprofit entities to carry out activities
				under this section.</text>
					</subsection><subsection id="H0AA8837406354A01963D67BB5F7C681C"><enum>(f)</enum><header>Coordination
				with other Federal agencies</header><text>Subject to subsection (h), the
				Secretary shall make information and analysis in the National Neurological
				Diseases Surveillance System available, as appropriate, to Federal departments
				and agencies, such as the National Institutes of Health, the Food and Drug
				Administration, the Centers for Medicare &amp; Medicaid Services, the Agency
				for Healthcare Research and Quality, the Department of Veterans Affairs, and
				the Department of Defense.</text>
					</subsection><subsection id="H1DD68B63ACD64AE7A22C5B8E737DE46E"><enum>(g)</enum><header>Public
				access</header><text>Subject to subsection (h), the Secretary shall make
				information and analysis in the National Neurological Diseases Surveillance
				System available, as appropriate, to the public, including researchers.</text>
					</subsection><subsection id="H2ACD7BDADD944F1383CD6585547C1433"><enum>(h)</enum><header>Privacy</header><text display-inline="yes-display-inline">The Secretary shall ensure that privacy and
				security protections applicable to the National Neurological Diseases
				Surveillance System are at least as stringent as the privacy and security
				protections under HIPAA privacy and security law (as defined in section
				3009(a)(2)).</text>
					</subsection><subsection id="H70232C8C2E164B8EBE6E0FFDDF6E9CEA"><enum>(i)</enum><header>Report</header><text>Not
				later than 4 years after the date of the enactment of this section, the
				Secretary shall submit a report to the Congress concerning the implementation
				of this section. Such report shall include information on—</text>
						<paragraph id="HC577B13B41574473A23F5B73784EE1C3"><enum>(1)</enum><text>the development
				and maintenance of the National Neurological Diseases Surveillance
				System;</text>
						</paragraph><paragraph id="HE40F1595222A484C94A1616D3810993B"><enum>(2)</enum><text>the type of
				information collected and stored in the System;</text>
						</paragraph><paragraph id="H7735C1B2E63E4CB48CBE2A1134ECE879"><enum>(3)</enum><text>the use and
				availability of such information, including guidelines for such use; and</text>
						</paragraph><paragraph id="HE6955E3B4117496CA92849FE21234212"><enum>(4)</enum><text>the use and
				coordination of databases that collect or maintain information on neurological
				diseases.</text>
						</paragraph></subsection><subsection id="H3DEEB52C90A2416689CB2ECDE8971977"><enum>(j)</enum><header>Definition</header><text>In
				this section, the term <term>national voluntary health association</term> means
				a national nonprofit organization with chapters, other affiliated
				organizations, or networks in States throughout the United States.</text>
					</subsection><subsection id="HDD6B8FA03C6D48B29C6FAE5D0F90E333"><enum>(k)</enum><header>Authorization of
				appropriations</header><text>To carry out this section, there is authorized to
				be appropriated $5,000,000 for each of fiscal years 2012 through
				2016.</text>
					</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body>
	<attestation>
		<attestation-group>
			<attestation-date chamber="House" date="20100928">Passed the House of
			 Representatives September 28, 2010.</attestation-date>
			<attestor display="yes">Lorraine C. Miller,</attestor>
			<role>Clerk.</role>
		</attestation-group>
	</attestation>
</bill>
